You searched for "therapeutics"
Endotypes in chronic rhinosinusitis: clinical relevance
Identifying endotypes enables personalised therapies that target specific pathophysiological processes, potentially resulting in better treatment outcomes for patients. The contemporary model of chronic rhinosinusitis (CRS) pathogenesis revolving around endotype, in combination with an expanding toolbox of diagnostics and therapeutics, enables...A place for everything and everything in its place: the practicalities of randomised clinical trials
Will this pill cure tinnitus? Bonnie Millar describes one trial that has investigated the possibility whilst describing the path of drug trials in the UK. Background In the last quarter of 2014, a clinical trial (QUIET-1; ClinicalTrials.gov Identifier: NCT02315508) commenced...2022 Hearing Technology Innovator Awards
Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, has announced a call for submissions for the third annual Hearing Technology Innovator Awards™. Through the annual awards programme, HHTM honours technological innovation...9th Beijing International Audiology Conference
The 9th Beijing International Audiology Conference, organised by the Beijing Society of Audiology, was successfully held at the China National Convention Center. Nearly 1000 distinguished audiology experts and industry specialists from both China and overseas gathered for this significant occasion.
Biologics for deafness
Cochlear implants and hearing aids are inherently limited in their ability to restore ‘natural’ hearing. Biological therapy to treat inner ear pathology still is evolving rapidly with several ongoing clinical trials, though none are available for clinical practice to date....BRS Juniors Day 2025
OCH AYE, THE BRS JUNIORS! A special update from the BRS Juniors Committee Joshua Michaels, ENT ST6, BRS Juniors Committee Member 2024/25 With a successful year of research, development and education delivered by the BRS Juniors' Committee, we had the...
